Prognostic Factors for Uterine Sarcoma and Carcinosarcoma: Insights from a 10-Year Follow-Up Study

Beata Kotowicz; Anna Dańska-Bidzińska; Małgorzata Fuksiewicz; Anna Nasierowska-Guttmejer; Dorota Raczkiewicz; Mariusz Gujski; Szymon Piątek; Mariusz Bidziński

doi:10.12659/MSM.941562

07 December 2023 : Clinical Research

Prognostic Factors for Uterine Sarcoma and Carcinosarcoma: Insights from a 10-Year Follow-Up Study

Beata Kotowicz

^1ACDEF*, Anna Dańska-Bidzińska

^2ABDEG, Małgorzata Fuksiewicz

^1BCDE, Anna Nasierowska-Guttmejer

^3BC, Dorota Raczkiewicz

^4C, Mariusz Gujski

^5BEF, Szymon Piątek

^6B, Mariusz Bidziński

^6AEG

DOI: 10.12659/MSM.941562

Med Sci Monit 2023; 29:e941562

Authors information Article notes Copyright and License information

Background Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Figure 5 Overall survival according to the concentration of CA 125 IU/mL. Created using Statistica 6.0 software STATSOFT, Kaplan-Meier survival analysis.

Back to the Article

Prognostic Factors for Uterine Sarcoma and Carcinosarcoma: Insights from a 10-Year Follow-Up Study

Your Privacy